We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Inflatable Aortic Valve Reduces Aortic Regurgitation

By HospiMedica International staff writers
Posted on 03 Dec 2012
An innovative transcatheter aortic valve (TAV) system virtually eliminates aortic regurgitation with no vascular complications. More...


The Direct Flow Medical (DFM) TAV System percutaneous aortic valve is designed to have the performance of a surgical valve with the attributes for transcatheter delivery, with the additional ability to be positioned, repositioned, and completely retrieved if necessary. The valve is based on an inflatable cuff with a conforming polymer support structure. Inflatable ventricular and aortic rings at the top and bottom of the valve are designed to conform and seal above and below the native valve. The lack of a metallic frame allows for a low profile, flexible, fully-sheathed system with the potential to reduce bleeding and vascular complications, particularly in patients with tortuous and variable anatomy. The valve is endovascularly delivered via a six mm introducer sheath.

The independently inflatable rings encircle and capture the native valve annulus to provide positive axial anchoring of the device. Inflation of the cuff with a saline and contrast solution renders the valve immediately functional and permits fluoroscopic visualization. Before final deployment, the saline and contrast mixture is exchanged under pressure, maintaining cuff shape and position, with a solidifying inflation media (IM) that hardens to form the permanent support structure. Full-thickness bovine pericardial leaflets are incorporated in the valve design for durability. The DFM TAV System is a product of Direct Flow Medical (Santa Rosa, CA, USA), and is currently approved as an investigational device.

“We designed the Direct Flow Medical System specifically to address complications that were problematic with earlier generations of transcatheter aortic heart valves,” said Charles Davidson, MD, clinical chief of cardiology at Northwestern Memorial Hospital (Chicago, IL, USA), and chief medical officer of Direct Flow Medical. “Our proprietary design takes a very different approach to restoring valvular flow, while being fully repositionable and retrievable.”

Related Links:
Direct Flow Medical
Northwestern Memorial Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.